enVVeno Medical Corporation

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Regulation FD disclosure Jul 14, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Apr 29, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release); Other events Feb 4, 2026 8-K Amended charter or bylaws Jan 20, 2026 8-K Shareholder vote results Dec 12, 2025 8-K Amended charter or bylaws Nov 20, 2025 8-K Regulation FD disclosure Nov 14, 2025 8-K Entered a material agreement Oct 30, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Delisting notice or listing-rule failure Oct 10, 2025 8-K Regulation FD disclosure Aug 20, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Director or officer change May 20, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 8-K Changed accountants Apr 21, 2025 10-K/A Fiscal year ended 2024-12-31 Feb 28, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Shareholder vote results Dec 26, 2024 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Entered a material agreement Sep 30, 2024 10-Q Quarter ended 2024-06-30 Jul 31, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Regulation FD disclosure Apr 24, 2024 8-K Regulation FD disclosure Mar 6, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Shareholder vote results Dec 7, 2023 8-K Regulation FD disclosure Nov 16, 2023 10-Q Quarter ended 2023-09-30 Oct 26, 2023 8-K Entered a material agreement; Unregistered sale of equity Oct 12, 2023 10-Q Quarter ended 2023-06-30 Jul 31, 2023 10-Q Quarter ended 2023-03-31 Apr 28, 2023 10-K Fiscal year ended 2022-12-31 Mar 2, 2023 8-K Shareholder vote results Dec 6, 2022 10-Q Quarter ended 2022-09-30 Oct 27, 2022 10-Q Quarter ended 2022-06-30 Aug 3, 2022 10-Q/A Quarter ended 2022-03-31 May 11, 2022 10-K/A Fiscal year ended 2021-12-31 May 11, 2022